Ontario Genomics’ BioCreate program is open to small- and medium-sized enterprises (SMEs) in southern Ontario seeking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture, and cleantech sectors at a Technology Readiness Level (TRL) of 4+. BioCreate will provide funding, access to mentorship and business support to enable companies to raise additional financing to achieve commercial outcomes.
The multi-phase BioCreate program will include direct, non-repayable funding of $150,000 that will be matched by an additional $100,000 (minimum) from participating companies to a total project size of $250,000 or more. Funded companies will have access to 18-months of intensive business mentorship and access to critical infrastructure provided by Ontario Genomics’ (OG’s) strategic sectoral and regional partnerships. Each cohort will conclude with an investor showcase, giving the companies an opportunity to pitch to investors and potential partners. BioCreate will support up to 32 high-potential companies over five years with seven total cohorts (rolling intake with funding decisions twice per year).
COHORT 2 – Spring 2023
Phase I – BioCreate Funding
- Complete intake form on OG website – rolling intake
- Intake start date: April 11, 2023
- Deadline to submit intake form to be considered for Cohort 2 is June 30, 2023
- Intake call with OG’s BioCreate team – rolling intake
- Applications for Cohort 2 due July 30, 2023
- Company pitch to BioCreate expert panel – week of September 11, 2023*
- Notification of award – September 2023*
- Contract executed – end of September 2023*
https://www.ontariogenomics.ca/funding-opportunities/open-competitions/biocreate/